Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Sildenafil NDC 42291-748 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Rev 1 - Label 4229174630 25mg 30ct. 2018
AVKARE is a prescription medication that comes in the form of tablets with NDC number of 42291-746-30. It contains Sildenafil as the active ingredient and is available in a pack of 30 tablets. It is only available on prescription.*
Label Rev 2 - Label 4229174730 50mg 30ct. 2018
Label Rev 3 - Label 4229174830 100mg 30ct. 2018
This is a description of the medication Sildenafil, marketed by AvKare under the National Drug Code (NDC) 42251-748-30. It is a tablet form of the medication with a strength of 100mg and is available by prescription only.*
chemical structure of sildenafil citrate - image 01
figure1 - image 02
figure2 - image 03
This is a chart that displays the change in systolic blood pressure (SBP) measured in millimeters of mercury (mmHg) over time post-dose (in hours). The chart compares two groups: one group receiving Doxazosin and placebo, and another group receiving Doxazosin and Sildenafil 25 milligrams. The values for SBP change are not provided in the text.*
figure3 - image 04
This appears to be a table or chart showing the change in systolic blood pressure (SBP) in millimeters of mercury (mmHg) after different treatments. The treatments compared seem to be a combination of Doxazosin and either placebo or Sildenafil 50 mg. However, without additional context or data, it's difficult to interpret the significance of these changes.*
figure4 - image 05
This appears to be a chart or graph that compares blood pressure measurements and treatments over time (in hours) with Doxazosin and either Sildenafil or Placebo. However, without additional context or data, it is not possible to provide a more detailed or accurate description of the information presented.*
figure5 - image 06
figure6 - image 07
figure7 - image 08
This is a graph showing the percentage of patients reporting improvement in a treatment group. The horizontal axis represents different treatment groups, and the vertical axis represents the percentage of patients reporting improvement. The treatment groups are identified as Placebo, Sildenafil 25mg, Sildenafil 50mg, and Sildenafil 100mg. The results indicate that 82% of patients who received Sildenafil 25mg reported improvement while only 7% of those who received Placebo reported improvement. The overall treatment has a p-value of less than 0.0001.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.